Key result
The LifePod web-based application is being evaluated in a 150-patient randomized controlled trial to determine its efficacy in improving submaximal exercise capacity in post-myocardial infarction patients compared to usual care.
Why the study?
Fulfillment of guideline-recommended cardiac rehabilitation targets after myocardial infarction is currently unsatisfactory, and whether web-based applications can improve risk factors and clinical outcomes compared with usual care requires evaluation.
Does a web-based lifestyle-focused application added to traditional cardiac rehabilitation improve submaximal exercise capacity in post-myocardial infarction patients?
RCT (n=150)
Open-label
Sealed envelopes
Yes
Does a web-based lifestyle-focused application added to traditional cardiac rehabilitation improve submaximal exercise capacity in post-myocardial infarction patients?
This study protocol outlines a randomized controlled trial to evaluate whether a web-based application can improve exercise capacity and risk factor management in post-MI patients undergoing cardiac rehabilitation.
No takes yet. Share an insight, caveat, or question.
Supports web-based apps for post-MI risk factor management; extends RCT evidence on digital secondary prevention.
González et al. (2019) conducted an RCT in Post-myocardial infarction (n=150). LifePod web-based application vs. Usual care was evaluated on Change in submaximal exercise capacity (in watts) between 2-4 weeks and 3-6 months post-discharge. The LifePod web-based application is being evaluated in a 150-patient randomized controlled trial to determine its efficacy in improving submaximal exercise capacity in post-myocardial infarction patients compared to usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: